Sphingolipids and atherosclerosis.
The atherosclerotic lesion contains a high amount of sphingolipids, a large group of structurally diverse lipids that regulate distinct biological functions beyond their role as structural membrane components. Assessment of their role in atherogenesis has been enabled after genes that regulate their metabolism had been identified and facilitated by the more wide availability of mass spectrometry. Here we discuss recent mechanistic insights obtained in animal and epidemiological studies that have greatly enhanced our understanding of mechanisms how sphingolipids affect the atherosclerotic process.
Inst. for Clinical Chemistry, University Hospital Zuerich, Raemistrasse 100, 8091 Zuerich, Switzerland. thorsten.hornemann@usz.ch
Thorsten
T
Hornemann
Tilla S
TS
Worgall
D000818:Animals; D050197:Atherosclerosis / Q000209:etiology*; D006801:Humans; D013107:Sphingolipids / Q000502:physiology*
D013107:Sphingolipids